is there room for innovation in today’s medical device industry?
DESCRIPTION
Stanton J. Rowe, Chief Scientific Officer, Edwards LifesciencesTRANSCRIPT
I th fI th fIs there room for Is there room for innovation in today’sinnovation in today’sinnovation in today s innovation in today s medical device industry?medical device industry?Stanton J. RoweStanton J. RoweChief Scientific OfficerChief Scientific OfficerChief Scientific Officer, Chief Scientific Officer, Edwards LifesciencesEdwards Lifesciences
LifeLife--Saving, LifeSaving, Life--Enhancing InnovationsEnhancing Innovations
Everyone Wants to HelpEveryone Wants to Help
Who We AreWho We Are
Who We AreWho We Are
Early Days of MedEarly Days of Med--Tech InnovationTech Innovation
Time from design to successful FIM:
2 years!
“Only” 50 Years Later!“Only” 50 Years Later!
Why So Challenging?Why So Challenging?
Tax impact Innovation time cost Physicians, payors –Tax impact Innovation time, cost Physicians, payors under stress
Regulations around the world
Evidence requirements –clinical, cost effectiveness
PMAPMA
PMA, the Rest!PMA, the Rest!
Today: Two Ways to Develop ProductsToday: Two Ways to Develop Products
High quality High quality• High-quality• Reasonable cost• Serviceable, practical
• High-quality• High cost• ExclusiveSe ceab e, p act ca
• Feature-rich• Variety within the category
Exclusive• Flashy• Limited portfolio
What Do Hospitals Want?What Do Hospitals Want?
The Innovation SpectrumThe Innovation Spectrum
Status quo
Iterating for innovation’s sake
Changing the norm
We can no longer iterate “in the middle”
Innovation is Still the AnswerInnovation is Still the Answer
Fundamentally improve patient
Impact health economics
outcomes
If truly innovative: BOTHIf truly innovative: BOTH
Adapt, SucceedAdapt, Succeed
Be ProactiveBe Proactive
• Invest in R&D• Prioritize development carefully• Improve/invest in quality systems serviceImprove/invest in quality systems, service• Generate evidence beyond safety
Effi– Efficacy– Cost effectiveness– Quality of life
• Be innovative in all facets of the device –procedure, distribution, emerging markets
Andersen & Colleagues: BalloonAndersen & Colleagues: Balloon--Expandable Aortic Heart ValveExpandable Aortic Heart Valve
• Porcine aortic valve sutured to a stainless
Expandable Aortic Heart ValveExpandable Aortic Heart Valve
sutured to a stainless steel frame• Crimped on a triple balloon catheter: 41F• IP acquired by Heartportp• No further development
European Society of Cardiology 1992European Society of Cardiology 1992
2002: Cribier Goes to First In Man2002: Cribier Goes to First In Man
Successful trans-septal placement of a 23mm equine pericardial valveSuccessful trans septal placement of a 23mm equine pericardial valve.Things begin to move very quickly from here.
Inspiration is Never Far AwayInspiration is Never Far Away
Inspiration is Never Far AwayInspiration is Never Far Away
“I started 20 years ago, and now it was used for sta ted 0 yea s ago, a d o t as used ohumans, treating patients.
Now there is an extra dimension – and that’s my father. Because now it’s going from son to fatherBecause now it s going from son to father,
into my own family.”
The Environment Has ChangedThe Environment Has Changed
Approximately 15% of SalesApproximately 15% of Sales ––Approximately 15% of Sales Approximately 15% of Sales ––Edwards is Committed to Extending Edwards is Committed to Extending its Leadership Through Innovationits Leadership Through Innovation
Those Who Adapt Will ThriveThose Who Adapt Will Thrive
Success: Helping Patients WorldwideSuccess: Helping Patients Worldwide